Related Experiment Video
Updated: May 5, 2026

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
Published on: August 12, 2014
Medical treatment versus endarterectomy for symptomatic carotid stenosis: systematic review and meta-analysis
José R Rodrigues1, Andreia Coelho2,3, Armando Mansilha2,4
1Faculty of Medicine, University of Porto, Porto, Portugal - jrodrigorodrigues@outllook.pt.
Insights
Best medical treatment for symptomatic carotid stenosis may show a trend toward higher stroke and death risks compared to revascularization. More long-term data is needed to fully assess the risk-benefit of medical versus invasive approaches.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Interventional Cardiology
Background:
- Symptomatic carotid stenosis treatment traditionally involves revascularization.
- Advances in medical treatment offer an alternative for low-risk patients.
- Limited long-term outcome data exists for medically treated patients, necessitating risk-benefit reassessment.
Purpose of the Study:
- To review evidence on long-term outcomes for symptomatic carotid stenosis patients managed with best medical treatment alone.
- To evaluate if additional revascularization provides benefits over best medical treatment.
Main Methods:
- A systematic review was conducted.
- Methodology adhered to Preferred Reporting Items for Systematic reviews and Meta-analysis (PRISMA) guidelines.
Main Results:
- The medical group showed a trend towards higher risks: stroke (6.96%), death (3.14%), and combined stroke or death (8.91%).
- Revascularization group risks were lower: stroke (4.51%), death (2.65%), and combined stroke or death (6.56%).
Conclusions:
- Despite advancements, long-term outcomes data for best medical treatment in symptomatic carotid stenosis is scarce.
- Future research should include medical treatment arms to accurately assess long-term event incidence.
Introduction:
The treatment of symptomatic carotid stenosis traditionally relies on revascularization procedures. However, evolution of medical treatment over the last decades, prompted the possibility to consider a best medical treatment approach as viable for the management of low-risk symptomatic patients. Nevertheless, there is limited evidence on the long-term outcomes of symptomatic patients treated medically, being critical to reassess the risk-benefit balance of invasive procedures in addition to best medical treatment. This study aims to review evidence on long-term outcomes of symptomatic carotid stenosis patients treated with best medical treatment alone and assess whether additional revascularization offers any beneficial effects.
Evidence Acquisition:
A systematic review was performed according to the recommendations of the Preferred Reporting Items for Systematic reviews and Meta-analysis statement and guidelines.
Evidence Synthesis:
There was a trend for a higher risk of stroke (pooled risk of 6.96% [95% confidence interval (CI): 4.76-9.15%]), death (pooled risk of 3.14% [95% CI: 1.64-4.64%]), and the combined outcome of stroke or death (pooled risk of 8.91% [95% CI: 6.49-11.33%]) in the medical group compared to patients undergoing revascularization procedures: 4.51% (95% CI: 2.67-6.35%), 2.65% (95% CI: 1.23-4.08%), and 6.56% (95% CI: 4.37-8.76%), respectively.
Conclusions:
While best medical treatment has undergone significant advancements in recent decades, there is scarce data regarding the long-term outcomes of symptomatic patients receiving such treatment. Future research investigating the treatment of symptomatic carotid stenosis by surgery or endovascular methods should incorporate medical treatment arms to accurately assess the incidence of recurrent events in patients undergoing best medical treatment in the long-term.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care

